MILLIPLEX^® 人神经退行性疾病磁珠板1-神经科学多重分析

MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

Luminex is a registered trademark of Luminex Corp

xMAP is a registered trademark of Luminex Corp

MILLIPLEX^® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 6 analytes in human serum, plasma, and cerebrospinal fluid (CSF).Analytes included: α-2-Macroglobulin, Apo AI, Apo CIII, Apo E, Complement C3, Complement Factor H.Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

For research use only. Not for use in diagnostic procedures.Label License/Sticker for Assay Product:By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.

Comprehensive Metabolic-Immune Profiling: Simultaneously quantify lipid metabolism markers, complement factors, and innate immune proteins, providing complete insight into the metabolic and inflammatory pathways driving neurodegeneration.Early-Stage Detection Power: Leverage biomarkers that show significant elevation in mild cognitive impairment.Batch-to-Batch Excellence: Trust in stringent manufacturing standards with verified lot-to-lot consistency ensuring reproducible results.All-in-One Research Solution: Receive complete experimental confidence with our comprehensive kit format containing all necessary reagents, eliminating procurement delays and ensuring seamless workflow execution.Dedicated Research Support: Partner with our specialized neuroscience application scientists and technical experts who can support your multiplex assay needs.

Disruptions in lipid transport and innate immunity are central to the pathology of neurodegenerative diseases. α-2-Macroglobulin, a broad-spectrum protease inhibitor, is closely linked to neuronal injury and Alzheimer′s progression. Apolipoproteins AI, CIII, and E orchestrate cholesterol balance and lipid trafficking—processes that falter early in cognitive decline. Meanwhile, complement proteins like C3 and Factor H influence synaptic pruning and amyloid clearance, with elevated levels often marking the onset of mild cognitive impairment.